HTA

The participants already have invested resources and expertise in Health Technology Assessment on a national level. Building on this, we will invest in further collaboration in this field. Our overall goals are to collaborate on a supranational level, leading to joint Health Technology Assessments, and to explore new mechanisms. For example, the mutual recognition of national assessments. This would also reduce the workload of national HTA-organizations.

We will continue to actively participate and coordinate efforts within EUnetHTA to facilitate international collaboration on Health Technology Assessment.

We aim to achieve:

  • Insight in the timelines of ongoing and future assessments;
  • Health Technology Assessment reports that are suitable for international use, by optimizing and harmonizing current reporting standards;
  • Joint assessments, both bilateral as well as within EUnetHTA;
  • The adoption of ‘non-national’ HTA-reports in national reimbursement decisions, by investigating and tackling the legislative hurdles.

Four types of collaboration are being studied in the Beneluxa initiative:

  1. Re-use of Health Technology Assessment (HTA) reports
    In this case, countries use parts of HTA-reports  of other countries
  2. Joint writing of an HTA report
    Authors of several countries join forces in order to write one report. This report can be used in all countries involved.
  3. Mutual recognition of HTA reports
    In this case, large parts of, or even a full, HTA-report of one country are adopted by others in a parallel process. The results of the assessments are then published at the same time. This has not been carried out yet.
  4. External referee
    HTA institutes of the various countries can also act as each other’s external referees in national procedures. It does not involve active work in a Health Technology Assessment itself.

First results
This table shows the first actual joint HTA procedures that were carried out. They were performed according to national legislation and based on actual submission files from the companies.

Overview HTA

Year Plan 2018 on Health Technology Assessment (HTA)
On January 17th 2018, the Steering Committee adopted in Luxembourg the Year Plan 2018 for the HTA Domain. Focus is primarily on 2 methods of collaboration: Joint Writing of assessments and Re-use of assessments. These methods will be applied when a pharmaceutical company cooperates with a joint Beneluxa assessment. Joint Writing (with or without re-use) will be carried out simultaneously by 2 (or more) HTA agencies after submission of a submission file by the pharmaceutical company. Re-use will be done by 1 or more agencies and is not limited to assessment reports within the Beneluxa initiative (e.g. EUnetHTA).